The Latin America, Middle East and Africa Biopsy Devices Market would witness market growth of 12.7% CAGR during the forecast period (2022-2028).
Biopsies can be executed in the erect or decubitus location with these add-on structures. Thus, patients who surpass the weight limit of the table for the prone biopsy device are appropriate applicants for tomosynthesis-guided biopsies.
Also, the patients with comorbidities (like respiratory issues, arthritic conditions, prior surgery, or limited mobility) that can stop them from lying on the radiosurgery table vulnerable for a long time are appropriate applicants for these biopsies.
Locating is much easy with the erect device as there is no disturbance from the biopsy table. In addition, posterior lesions are much effortlessly biopsied as the erect perspective allows better entrance to the posterior tissues.
Compared to other Middle East countries, Egypt has a large healthcare sector. As the government of Egypt is intensely interested in growing the healthcare sector, Egypt bids a lot of prospects in developing medical services. In the past year, Egypt has raised public investment by 205%, allowing for the bolstering of the healthcare system during the pandemic.
The Brazil market dominated the LAMEA Biopsy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $53.1 million by 2028.The Argentina market is experiencing a CAGR of 13.3% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 12.4% during (2022 - 2028).
Based on Product, the market is segmented into Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps and Others. Based on Needle-based Biopsy Guns Type, the market is segmented into Vacuum-assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices and Core Needle Biopsy (CNB) Devices. Based on Biopsy Guidance Systems Type, the market is segmented into Manual and Robotic. Based on Biopsy Needles Type, the market is segmented into Disposable and Reusable. Based on End User, the market is segmented into Hospitals, Diagnostic & Imaging Center and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Biopsy Devices Market is Predict to reach $3 Billion by 2028, at a CAGR of 7.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
By Product
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
